Dextromethorphan and dextrorphan as calcium channel antagonists

Brain Res. 1988 Jan 26;439(1-2):372-5. doi: 10.1016/0006-8993(88)91497-7.

Abstract

Dextromethorphan and dextrorphan, which reduce excitatory amino acid-induced neurotoxicity, decreased K+ depolarization-evoked 45Ca2+ uptake into brain synaptosomes and cultured neural (PC12) cells. Half-maximal inhibition of synaptosomal 45Ca2+ uptake occurred with 48 microM dextromethorphan or 200 microM dextrorphan, which are similar to concentrations associated with protection from excitotoxicity. The ability to decrease Ca2+ flux through N-type (synaptosomal) and L-type (PC12) voltage-gated Ca2+ channels may therefore contribute to the neuroprotective effects of these compounds.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Brain / metabolism*
  • Calcium / metabolism*
  • Calcium Channel Blockers*
  • Dextromethorphan / pharmacology*
  • Dextrorphan / pharmacology*
  • Ion Channels / drug effects
  • Ion Channels / metabolism*
  • Kinetics
  • Levorphanol / analogs & derivatives*
  • Male
  • Morphinans / pharmacology*
  • Potassium / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Synaptosomes / metabolism*

Substances

  • Calcium Channel Blockers
  • Ion Channels
  • Morphinans
  • Dextrorphan
  • Levorphanol
  • Dextromethorphan
  • Potassium
  • Calcium